Summary NovaBay Pharmaceuticals Inc (NovaBay), formerly NovaCal Pharmaceuticals Inc is a biopharmaceutical company that discovers and develops eyecare products.The company’s products include skin and wound cleanser, daily lid and lash hygiene spray solutions, and cosetic procedures.
Its daily lid and lash hygiene spray solution helps in removal of foreign materials such as microorganisms and debris on and around the lid and eyelid margins.NovaBay develops aganocide compound through research and development based on the human body’s natural immune system and molecules involved in combating infections.
The company’s products find application in therapeutic areas such as ophthalmology, wound care, dermatology, and neutrophase.It partners with pharmaceutical and biotech companies.
NovaBay is headquartered in Emeryville, California, the US.
NovaBay Pharmaceuticals Inc (NBY) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings.The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period.
The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope - Financial Deals - Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. - Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. - Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. - Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. - Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector. - Major Deals - Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios. - Business Description - A brief description of the company’s operations. - Key Employees - A list of the key executives of the company. - Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company. - Key Competitors - A list of the key competitors of the company. - Key Recent Developments - A brief on recent news about the company.
Reasons to Buy Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements - The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy - The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers. - The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Our reports have been used by over 10K customers, including:
The Global Joint Venture Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014-2021 report provides comprehensive understanding and unprecedented access to the joint venture deals and agreements entered into by the worlds leading life science companies. This report provides details of the latest joint...
The Global Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014-2021 report. This report provides details of the latest manufacturing and supply agreements announced in the pharmaceutical, biotechnology, device and diagnostic sectors. Fully revised and updated, the report...
In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global Ultrapure Water Market Report The ultrapure water market was valued at USD 7.15 billion in 2020 and is expected to reach USD 11.21 billion in 2026 growing at a CAGR of 7.78%. The following factors are likely to contribute to the growth...
Pharmaceutical Incubators market is one of the high-growth prospect industries with potential opportunities throughout 2028. The Pharmaceutical Incubators Market growth analysis and insights report analyzes emerging market trends, market size outlook, potential opportunities, market share by Pharmaceutical Incubators types, applications. Further,...
The cleanroom technology market is expected to reach US$ 8,356.97 million by 2028 from US$ 5,233.63 million in 2021; it is estimated to grow at a CAGR of 6.9% from 2021 to 2028. A few factors such as increasing adoption in the biopharmaceuticals industry and technological advancements in cleanrooms are driving the growth of the market. However,...
2021 What’s Ahead for the Pharmaceutical Industry?--Emerging Opportunities and Growth Strategies for Suppliers The series includes current assessments of more than 1,000 companies worldwide. Depending on the company’s business nature and structure, the assessments include all or some of the following analyses:...
This report is 90% complete and will include the latest impact analysis of Covid-19 along with updated quarterly market data for the year 2021 (estimated). This report will be delivered within three working days post order confirmation. Global Genomic Medicine Market - Global Industry Size, Share, Trends, Opportunity...
The global aseptic packaging market is expected to grow at a CAGR of around 7% during 2021-2026. Aseptic packaging is the process wherein packaging materials are sterilized and filled with ultra-high temperature (UHT) processed contents. These packaging materials are treated with irradiation, heat and chemicals that...
The global biological safety cabinet market reached a value of US$ 188 Million in 2020. Looking forward, the analyst expects the market to grow at a CAGR of 7.8% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of...
The global alzheimer’s drugs market reached a value of US$ 6.34 Billion in 2020. Looking forward, the analyst expects the market to grow at a CAGR of 6.50% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.